RNAi suppressor P19 can be broadly exploited for enhanced adenovirus replication and microRNA knockdown experiments

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Rauschhuber, Christina ^a   Mueck Haeusl, Martin ^a   Zhang, Wenli ^a,c   Nettelbeck, Dirk M ^b   Ehrhardt, Anja ^a,c  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c Institute of Virology and Microbiology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; ONCOLYTIC VIRUS; P19 PROTEIN, TOMATO BUSHY STUNT VIRUS; VIRUS PROTEIN;

ADENOVIRUS; ANTIBODY SPECIFICITY; ARTICLE; CYTOPATHOGENIC EFFECT; GENE EXPRESSION REGULATION; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; RNA INTERFERENCE; TUMOR CELL LINE; VIRUS REPLICATION;

ADENOVIRIDAE; CELL LINE, TUMOR; CYTOPATHOGENIC EFFECT, VIRAL; GENE EXPRESSION REGULATION, VIRAL; GENETIC VECTORS; HUMANS; MICRORNAS; ONCOLYTIC VIRUSES; ORGAN SPECIFICITY; RNA INTERFERENCE; TRANSDUCTION, GENETIC; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 84875199293     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep01363     Document Type: Article

References (29)

1. Grundhoff, A. & Sullivan, C. S. Virus-encoded microRNAs. Virology 411, 325-343 (2011).
2. Filipowicz, W., Bhattacharyya, S. N. & Sonenberg, N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nature reviews. Genetics 9, 102-114 (2008).
3. Lecellier, C. H. et al. A cellular microRNA mediates antiviral defense in human cells. Science 308, 557-560 (2005).
4. Umbach, J. L. et al.MicroRNAs expressed by herpes simplex virus 1 during latent infection regulate viral mRNAs. Nature 454, 780-783 (2008).
5. Pfeffer, S. et al. Identification of virus-encoded microRNAs. Science 304, 734-736 (2004). (Pubitemid 38560879)
6. Dolken, L. et al. Mouse cytomegalovirus microRNAs dominate the cellular small RNA profile during lytic infection and show features of posttranscriptional regulation. Journal of virology 81, 13771-13782 (2007). (Pubitemid 350247870)
7. Sullivan, C. S., Grundhoff, A. T., Tevethia, S., Pipas, J. M. & Ganem, D. SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells. Nature 435, 682-686 (2005). (Pubitemid 40825513)
8. Andersson, M. G. et al. Suppression of RNA interference by adenovirus virus-associated RNA. Journal of virology 79, 9556-9565 (2005). (Pubitemid 41022298)
9. Aparicio, O., Razquin, N., Zaratiegui, M., Narvaiza, I. & Fortes, P. Adenovirus virus-associated RNA is processed to functional interfering RNAs involved in virus production. Journal of virology 80, 1376-1384 (2006). (Pubitemid 43134095)
10. Rauschhuber, C. & Ehrhardt, A. RNA interference is responsible for reduction of transgene expression after Sleeping Beauty transposase mediated somatic integration. PloS one 7, e35389 (2012).
11. Yant, S. R. et al. Transposition from a gutless adeno-transposon vector stabilizes transgene expression in vivo. Nature biotechnology 20, 999-1005 (2002).
12. Hu, C., Cela, R. G., Suzuki, M., Lee, B. & Lipshutz, G. S. Neonatal helper-dependent adenoviral vector gene therapy mediates correction of hemophilia A and tolerance to human factor VIII. Proceedings of the National Academy of Sciences of the United States of America 108, 2082-2087 (2011).
13. Schiedner, G. et al.GenomicDNAtransfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nature genetics 18, 180-183 (1998). (Pubitemid 28082470)
14. Yamamoto, M. & Curiel, D. T. Current issues and future directions of oncolytic adenoviruses. Molecular therapy: the journal of the American Society of Gene Therapy 18, 243-250 (2010).
15. Liu, T. C., Galanis, E. & Kirn, D. Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress. Nature clinical practice. Oncology 4, 101-117 (2007). (Pubitemid 46189539)
16. Alemany, R., Balague, C. & Curiel, D. T. Replicative adenoviruses for cancer therapy. Nature biotechnology 18, 723-727 (2000). (Pubitemid 30460686)
17. Dunoyer, P., Lecellier, C. H., Parizotto, E. A., Himber, C. & Voinnet, O. Probing the microRNA and small interfering RNA pathways with virus-encoded suppressors of RNA silencing. The Plant cell 16, 1235-1250 (2004). (Pubitemid 38641517)
18. Scholthof, H. B. The Tombusvirus-encoded P19: from irrelevance to elegance. Nature reviews. Microbiology 4, 405-411 (2006). (Pubitemid 43771858)
19. Mathews, M. B. & Shenk, T. Adenovirus virus-associated RNA and translation control. Journal of virology 65, 5657-5662 (1991).
20. Jager, L. et al. A rapid protocol for construction and production of high-capacity adenoviral vectors. Nature protocols 4, 547-564 (2009).
21. Palmer, D. & Ng, P. Improved system for helper-dependent adenoviral vector production. Molecular therapy: the journal of the American Society of Gene Therapy 8, 846-852 (2003). (Pubitemid 37527461)
22. Miao, C. H. et al. Inclusion of the hepatic locus control region, an intron, and untranslated region increases and stabilizes hepatic factor IX gene expression in vivo but not in vitro. Molecular therapy: the journal of the American Society of Gene Therapy 1, 522-532 (2000).
23. Lagos-Quintana, M., Rauhut, R., Lendeckel, W. & Tuschl, T. Identification of novel genes coding for small expressed RNAs. Science 294, 853-858 (2001). (Pubitemid 33032103)
24. Chen, J. F. et al. Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure. Proceedings of the National Academy of Sciences of the United States of America 105, 2111-2116 (2008).
25. Khare, R., Chen, C. Y., Weaver, E. A. & Barry, M. A. Advances and future challenges in adenoviral vector pharmacology and targeting. Current gene therapy 11, 241-258 (2011).
26. Sadeghi, H. & Hitt, M. M. Transcriptionally targeted adenovirus vectors. Current gene therapy 5, 411-427 (2005). (Pubitemid 41052432)
27. Rivera, A. A. et al. Mode of transgene expression after fusion to early or late viral genes of a conditionally replicating adenovirus via an optimized internal ribosome entry site in vitro and in vivo. Virology 320, 121-134 (2004). (Pubitemid 38296719)
28. Cascallo, M. et al. Deletion of VAI and VAII RNA genes in the design of oncolytic adenoviruses. Human gene therapy 17, 929-940 (2006). (Pubitemid 46076753)
29. Rauschhuber, C., Xu, H., Salazar, F. H., Marion, P. L. & Ehrhardt, A. Exploring gene-deleted adenoviral vectors for delivery of short hairpin RNAs and reduction of hepatitis B virus infection in mice. The journal of gene medicine 10, 878-889 (2008).